LPAR1 and brain ischemia: To address whether LPA1 could mediate brain damage in cerebral ischemia, mice were challenged with tMCAO and received an LPA1 antagonist, AM095 (30 mg/kg, p.o.), immediately after reperfusion followed by assessment of brain damage at 1 day after tMCAO.